Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enzalutamide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02642913
What this trial is testing

Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT01534052
What this trial is testing

Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)
Astellas Pharma Inc 52
Testing effectiveness (Phase 2)Study completedNCT02034552
What this trial is testing

Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)

Who this might be right for
Prostatic Neoplasms
Bayer 68
Testing effectiveness (Phase 2)Ended earlyNCT04179864
What this trial is testing

Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer

Who this might be right for
Metastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
Epizyme, Inc. 102
Testing effectiveness (Phase 2)Study completedNCT02429193
What this trial is testing

Biomarkers of Androgen Response and Resistance In Evolution During a Rising PSA

Who this might be right for
Castration-resistant Prostate Cancer
University Health Network, Toronto 16
Large-scale testing (Phase 3)Active Not RecruitingNCT06691984
What this trial is testing

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 707
Early research (Phase 1)Study completedNCT02300610
What this trial is testing

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Who this might be right for
Bladder CancerCarcinoma, Transitional CellRenal Pelvis Cancer+2 more
H. Lee Moffitt Cancer Center and Research Institute 10
Testing effectiveness (Phase 2)Study completedNCT03103724
What this trial is testing

A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.

Who this might be right for
Carcinoma Prostate
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 68
Testing effectiveness (Phase 2)Study completedNCT03338790
What this trial is testing

An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 292
Testing effectiveness (Phase 2)Ended earlyNCT03869762
What this trial is testing

Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.

Who this might be right for
Castration-resistant Prostate CancerMetastatic CancerBone Metastases
Cancer Trials Ireland 7
Testing effectiveness (Phase 2)Looking for participantsNCT05393791
What this trial is testing

Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Leiden University Medical Center 168
Post-approval studies (Phase 4)Study completedNCT01995513
What this trial is testing

Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Pfizer 509
Testing effectiveness (Phase 2)Study completedNCT03418324
What this trial is testing

Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy

Who this might be right for
Prostate Cancer
Cedars-Sinai Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT02125357
What this trial is testing

Sequencing Abiraterone and Enzalutamide in mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
British Columbia Cancer Agency 202
Testing effectiveness (Phase 2)Active Not RecruitingNCT02452008
What this trial is testing

Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)WithdrawnNCT03709550
What this trial is testing

Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma in the Soft Tissue+6 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT02124668
What this trial is testing

Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Who this might be right for
Castration-Resistant Prostate CancerProstate Cancer
Astellas Pharma Europe B.V. 30
Large-scale testing (Phase 3)Ended earlyNCT03850795
What this trial is testing

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer MetastaticCastration-resistant Prostate Cancer
Hinova Pharmaceuticals USA, Inc. 104
Not applicableUnknownNCT05339672
What this trial is testing

Determining the Clinical Relevance of the Interaction Between Enzalutamide and the Opioid Morphine and the DOAC Edoxaban

Who this might be right for
Drug-drug Interaction
Radboud University Medical Center 26
Testing effectiveness (Phase 2)UnknownNCT02254785
What this trial is testing

Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostatic Cancer
British Columbia Cancer Agency 120
Next Page